Zhang Huamin, Zhou Yutong, Jiang Canhua, Jian Ni, Wang Jie
Department of Immunology, Xiangya School of Medicine, Central South University, Changsha, 410078, China.
Department of Oral and Maxillofacial Surgery, Xiangya Hospital, Central South University, Changsha, 410078, China.
Int J Biol Sci. 2024 Jul 8;20(10):3802-3822. doi: 10.7150/ijbs.93644. eCollection 2024.
Chronic tissue injury triggers changes in the cell type and microenvironment at the site of injury and eventually fibrosis develops. Current research suggests that fibrosis is a highly dynamic and reversible process, which means that human intervention after fibrosis has occurred has the potential to slow down or cure fibrosis. The ubiquitin system regulates the biological functions of specific proteins involved in the development of fibrosis, and researchers have designed small molecule drugs to treat fibrotic diseases on this basis, but their therapeutic effects are still limited. With the development of molecular biology technology, researchers have found that non-coding RNA (ncRNA) can interact with the ubiquitin system to jointly regulate the development of fibrosis. More in-depth explorations of the interaction between ncRNA and ubiquitin system will provide new ideas for the clinical treatment of fibrotic diseases.
慢性组织损伤会引发损伤部位细胞类型和微环境的变化,最终发展为纤维化。目前的研究表明,纤维化是一个高度动态且可逆的过程,这意味着在纤维化发生后进行人为干预有可能减缓或治愈纤维化。泛素系统调节参与纤维化发展的特定蛋白质的生物学功能,研究人员在此基础上设计了治疗纤维化疾病的小分子药物,但其治疗效果仍然有限。随着分子生物学技术的发展,研究人员发现非编码RNA(ncRNA)可与泛素系统相互作用,共同调节纤维化的发展。对ncRNA与泛素系统之间相互作用的更深入探索将为纤维化疾病的临床治疗提供新思路。